Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on NIGHTHAWK ENERGY PLC. We currently have 7 research reports from 2 professional analysts.
|15Feb17 07:00||RNS||Update re Operations and Year-end Reserves|
|26Jan17 07:00||RNS||Correction - Production Update|
|24Jan17 07:00||RNS||Production Update|
|18Jan17 16:35||RNS||Price Monitoring Extension|
|12Jan17 07:00||RNS||Operations Update|
|03Jan17 07:00||RNS||Company Update|
|16Dec16 07:00||RNS||Monarch JDA Settlement Agreement|
Frequency of research reports
Research reports on
NIGHTHAWK ENERGY PLC
NIGHTHAWK ENERGY PLC
Small Cap Breakfast
15 Feb 17
Xafinity –Publication of prospectus. The pensions actuarial, consulting and administration business has conditionally raised £179.6m. At 139p. Due to join main market 16 Feb. Guinness Oil & Gas Exploration—Publication of prospectus. Seeking to raise £50m and invest in 15 exploration companies at launch, with plans to grow the portfolio to 30 positions during its lifetime. Issue closing 23 Feb. Arix Bioscience — Intention to float on the main market from the global healthcare and life science company supporting medical innovation. Raised £52m in Feb 16 with investors including Woodford Investment Management
Funded to initiate Waterflood Pilot
04 Aug 16
We maintain our Buy rating on Nighthawk Energy and 7p target price following encouraging recent developments, particularly on funding and progress with the Arikaree Creek Waterflood Pilot project, which demonstrate the strong support of existing shareholders and the quality of the underlying assets. Nighthawk has an attractive portfolio of low-cost, conventional production and development assets in the Denver-Julesberg basin, one of the more underdeveloped hydrocarbon provinces remaining onshore US.
03 Feb 16
We reiterate our Buy rating and revise our target price to 7p following the recent production and revenue guidance update. Nighthawk has endured a challenging few months with poor drilling results from its Monarch JV assets and a reduction in its RBL borrowing base. Its near-term focus on operational efficiency and cash preservation should however set the company up well to take advantage of its low cost, high return conventional production and development assets as the macro-environment improves through 2016.
RBL redetermination not an issue
04 Nov 15
We reiterate our Buy rating and retain our 12.5p price target following news of a redetermination of the borrowing base under the RBL the company has with the Commonwealth Bank of Australia. Nighthawk as adequate liquid funds to meet potential repayments and to fund the remaining wells under the 2015 drilling programme. As we highlighted in our recent note “A turning point for the E&P sector”, we are positive on oil and the E&P sector and would buy into any weakness in the share price on the back of this news.
Oil & Gas - A turning point for the E&P sector
28 Oct 15
We suggest that, following 4½ years of underperformance, the E&P sector is set for a sharp recovery relative to the market. We think that this will be driven by a dramatic reversal in E&P margins, as a recovery in oil prices coincides with reductions in upstream costs, similar to what happened in 2003/04 (following the consolidation of the majors) and 2009/10 (post the financial crisis). We focus our stock recommendations on our corporate clients – Andes Energia, Nighthawk Energy and Oilex - but acknowledge that the entire sector should participate in the recovery.
Profitable even at these low oil prices
05 Oct 15
We reiterate our Buy rating and 12.5p target price on Nighthawk Energy following a solid set of interim results. Nighthawk is focused on low-cost, conventional oil production from an underdeveloped onshore province in the US. The company remains profitable, even at these low oil prices, and, following the successful convertible loan issue, is funded to drill new wells that can drive production and cash flow growth in the near term. Nighthawk is currently trading at a 25% discount to core NAV.
20 Feb 17
Hayward Tyler Group* (HAYT): Trading update and financial position (CORP) | Petra Diamonds (PDL): Interim results (BUY) | Gemfields* (GEM): Interim results (CORP) | Premaitha Health* (NIPT): Middle East momentum (CORP) | Sound Energy (SOU): Acquisition update and TE-8 well spud (HOLD) | Proactis* (PHD): Interim trading on track (CORP) | 7digital* (7DIG): Automotive contract win (CORP)
The Slide Rule
12 Jan 17
What is The Slide Rule? The Slide Rule has been designed to dramatically simplify the identification of the best companies in the UK small/mid-cap sector by making a quantitative assessment of the relative potential of each company. At its core, The Slide Rule aims to identify those companies that create genuine shareholder value through strong returns on capital and solid growth, but also present a value opportunity with the potential tailwind of earnings momentum. Companies are assessed within a Quality, Value, Growth and Momentum (QVGM) framework.
Playing the long term, with short-term risks
16 Feb 17
After the publication of the annual results, we update our view and highlight the key points. Q4 16 key highlights As a reminder, the company reported results 30% below expectations at $400m for Q4 16. By division: 1) In upstream, underlying replacement costs profit came to $400m, vs. a loss a year earlier of $728m and a loss of $224m in Q3 16, reflecting the ongoing lower costs which have benefited from simplifications, efficiencies and lower exploration write-offs. In the US, the loss is still $147m. Production came in at 2.19mbpd, down 5.5% yoy due to disposals and up 1.8% on an underlying basis thanks to ramp-ups. One of the key events during the quarter was the renewal of BP’s onshore concession in the UAE with a 10% interest in the ADCO onshore oil concession. In terms of outlook, production should be higher in 2017 and will depend on the timing of project start-ups, acquisitions, divestments, and OPEC quota. Also the Abu Dhabi concession will be visible as from Q1 17. 2) In downstream, replacement costs profit came to $877m, down from $1.2bn a year ago and $1.4bn in Q3 16. The US division showed a loss of $371m vs a gain of $1.25bn. Non-US Fuel business earnings halved to $417m due to the weaker refining environment as well as the impact from the particularly large turnaround at the Whiting refinery. In lubricants, profit rose to $357m, reflecting the continued strong performance in its growth markets and premium brands as well as simplifications and greater efficiencies. The margin should remain unchanged for Q1 17. 3) Rosneft. Underlying replacement costs profit came to $135m, down from $235m a year ago, affected by the increased government take. Production was at 1.15mbpd, up from 1.03mbpd a year ago. This reflects the completion of the acquisition of Bashneft and Rosneft’s increased stake in the PetroMonagas venture. BP received a dividend of $322m after deduction of the withholding tax, in July 2016. On the Macondo oil spill, the charge taken for the Q4 16 pre-tax was $530m. This reflects BP’s latest estimates for claims including business economic loss. The pre-tax cash outflow on costs related to the oil spill for the full year 2016 was $7.1bn. Cash flow Excluding the Gulf of Mexico payment, the operating cash flow was $4.5bn. Underlying operating cash flow excluding the oil spill-related payment was $17.8bn for the full year. Proceeds during the year and the scrip dividend were not enough to cover capex and the cash dividend. Gearing at the end of the year increased to 27% ($35.5bn debt), in the high range of the group’s target of 20-30%. Organic capital was $16bn, below original guidance of $17bn to $19bn. Capex in 2017 should be close to $16-17bn. Divestment proceeds should be higher in 2017, close to $5bn and then reducing by $2-3bn per year after 2018. The total costs of the Deepwater payment should fall to $2bn in 2018 and then $1bn per year as from 2019. In 2017, this should be close to $5bn. All in all, including the latest acquisitions, cash flow break-even should be close to $60/bbl in 2017.
Small Cap Breakfast
16 Feb 17
Saffron Energy—Schedule One update. Raising £2.5m, expected Mkt Cap £7.7m. Admission due 24 Feb. Italian Oil & Gas Play Guinness Oil & Gas Exploration—Publication of prospectus. Seeking to raise £50m and invest in 15 exploration companies at launch, with plans to grow the portfolio to 30 positions during its lifetime. Issue closing 23 Feb. Arix Bioscience — Intention to float on the main market from the global healthcare and life science Company supporting medical innovation. Raised £52m in Feb 16 with investors including Woodford Investment Management
GMP FirstEnergy ― UK Energy morning research package
17 Feb 17
Enquest (ENQ LN): Speculative Buy, £0.65: Kraken FPSO in the field and hooked up in the North Sea | Ithaca Energy (IAE LN/CN)6: BUY, £1.40: Stella First Hydrocarbons in the North Sea | Bowleven (BLVN LN) (not covered): Denies claims made by Crown Ocean Capital